NLRP3 and neoplasm: 3 Compared with the KYSE150-N + Fn group, NSG mice in the KYSE150-N + Fn + CDDP group showed a significantly reduced tumour-forming ability (p < 0.05), suggesting that NLRP3 knockdown combined with CDDP treatment could more effectively inhibit malignant proliferation.